Quest Diagnostics (FRA:QDI) Debt-to-Equity : 0.83 (As of Mar. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Quest Diagnostics Debt-to-Equity?

Quest Diagnostics's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was €974 Mil. Quest Diagnostics's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was €3,950 Mil. Quest Diagnostics's Total Stockholders Equity for the quarter that ended in Mar. 2024 was €5,917 Mil. Quest Diagnostics's debt to equity for the quarter that ended in Mar. 2024 was 0.83.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Quest Diagnostics's Debt-to-Equity or its related term are showing as below:

FRA:QDI' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.69 Med: 0.8 Max: 1.12
Current: 0.83

During the past 13 years, the highest Debt-to-Equity Ratio of Quest Diagnostics was 1.12. The lowest was 0.69. And the median was 0.80.

FRA:QDI's Debt-to-Equity is ranked worse than
80% of 195 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.22 vs FRA:QDI: 0.83

Quest Diagnostics Debt-to-Equity Historical Data

The historical data trend for Quest Diagnostics's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quest Diagnostics Debt-to-Equity Chart

Quest Diagnostics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.96

0.71

0.74

0.80

0.87

Quest Diagnostics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial															0.76	0.79	0.77	0.87	0.83

Competitive Comparison of Quest Diagnostics's Debt-to-Equity

For the Diagnostics & Research subindustry, Quest Diagnostics's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Quest Diagnostics's Debt-to-Equity Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Quest Diagnostics's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Quest Diagnostics's Debt-to-Equity falls into.

Quest Diagnostics Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Quest Diagnostics's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(536.445	+	4505.221)	/	5783.519
	=	0.87

Quest Diagnostics's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(974.28	+	3949.56)	/	5917.44
	=	0.83

Quest Diagnostics (FRA:QDI) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Quest Diagnostics Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Quest Diagnostics's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Quest Diagnostics (FRA:QDI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Quest Diagnostics Inc (FRA:QDI) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

DGX:USA

Address

500 Plaza Drive, Secaucus, NJ, USA, 07094

Website

https://www.questdiagnostics.com

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.

Quest Diagnostics (FRA:QDI) Headlines

No Headlines